IDC:全球次季PC出貨量升13.2%至8,360萬臺 聯想(00992.HK)市佔續排第一
調查機構IDC發表的報告指,儘管受環球零部件短缺及物流因素影響,PC需求在今年第二季維持強勁,全球出貨量按年升13.2%至8,360萬臺。該行指出PC市場繼續帶動供應方面的投資,包括有新品牌加入等,而五大品牌繼續帶動銷量增長,小型品牌亦有透過獨特設計或功能推動增長。
按品牌劃分,聯想(00992.HK)出貨量按年增14.9%至2,000.5萬臺,市佔率23.9%排全球首位,出貨量排第二的是HP(HPQ.US),按年升2.7%至1,859.4萬臺,而Dell(DELL.US)則以1,397.6萬臺排名第三。蘋果(AAPL.US)出貨量則按年升9.4%至615.6萬臺排第四。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.